Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-analysis

Annals of Surgery

Volumn 254, Issue 6, 2011, Pages 894-906

  Boshier, Piers R ^a   Anderson, Oliver ^a   Hanna, George B ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOSIS LEAKAGE; ATELECTASIS; BLEEDING; CANCER SURGERY; ESOPHAGOGASTRIC CANCER; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; LYMPHADENECTOMY; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY TRACT DISEASE; REVIEW; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; TRANSHIATAL ESOPHAGECTOMY; TRANSTHORACIC ESOPHAGECTOMY; WOUND INFECTION;

ABDOMEN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTRECTOMY; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; NECK; POSTOPERATIVE COMPLICATIONS; STOMACH NEOPLASMS; THORACOTOMY;

EID: 81855170058     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182263781     Document Type: Review

References (138)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;49:2241-2252.
2. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8:545-553.
3. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?. Aust N Z J Surg. 1999;69:187-194.
4. Hulscher JB, Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306-313.
5. Rodgers M, Jobe BA, O'Rourke RW, et al. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg. 2007;142:829-839.
6. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-2127.
7. Yasunaga H, Matsuyama Y, Ohe K. Effects of hospital and surgeon casevolumes on postoperative complications and length of stay after esophagectomy in Japan. Surg Today. 2009;39:566-571.
8. Santin B, Kulwicki A, Price P. Mortality rate associated with 56 consecutive esophagectomies performed at a "low-volume" hospital: is procedure volume as important as we are trying to make it?. J Gastrointest Surg 2008;12:1346-1350.
9. Padmanabhan RS, Byrnes MC, Helmer SD, et al. Should esophagectomy be performed in a low-volume center?. Am Surg 2002;68:348-352.
10. Miller JD, Jain MK, de Gara CJ, et al. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol. 1997;65:20-21.
11. Migliore M, Choong CK, Lim E, et al. A surgeon's case volume of oesophagectomy for cancer strongly influences the operative mortality rate. Eur J Cardiothorac Surg. 2007;32:375-380.
12. Pal N, Axisa B, Yusof S, et al. Volume and outcome for major upper GI surgery in England. J Gastrointest Surg. 2008;12:353-357.
13. Skipworth RJ, Parks RW, Stephens NA, et al. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003. Eur J Surg Oncol. 2010;36:141-147.
14. Dimick JB, Pronovost PJ, Cowan JA, et al. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications?. Ann Thorac Surg. 2003;75:337-341.
15. Meguid RA, Weiss ES, Chang DC, et al. The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence?. J Thorac Cardiovasc Surg. 2009;137:23-29.
16. Urbach DR, Bell CM, Austin PC. Differences in operative mortality between high-and low-volume hospitals in Ontario for 5major surgical procedures: estimating the number of lives potentially saved through regionalization. CMAJ. 2003;168:1409-1414.
17. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747-1751.
18. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137.
19. Bilimoria KY, Bentrem DJ, Talamonti MS, et al. Risk-based Selective Referral for Cancer Surgery: A Potential Strategy to Improve Perioperative Outcomes. Ann Surg. 2009;251:708-716.
20. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126-1132.
21. Patti MG, Corvera CU, Glasgow RE, et al. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg. 1998;2:186-192.
22. Kuo EY, Chang Y, Wright CD. Impact of hospital volume on clinical and economic outcomes for esophagectomy. Ann Thorac Surg. 2001;72:1118-1124.
23. Reavis KM, Smith BR, Hinojosa MW, et al. Outcomes of esophagectomy at academic centers: an association between volume and outcome. Am Surg. 2008;74:939-943.
24. Connors RC, Reuben BC, Neumayer LA, et al. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17, 395 patients. J Am Coll Surg. 2007;205:735-740.
25. Birkmeyer JD, Finlayson EV, Birkmeyer CM. Volume standards for highrisk surgical procedures: potential benefits of the Leapfrog initiative. Surgery. 2001;130:415-422.
26. Yasunaga H, Matsuyama Y, Ohe K. Volume-outcome relationship in rectal cancer surgery: a new perspective. Surg Today. 2009;39:663-668.
27. Dickson GH, Waters R, Bull J, et al. Should we continue oesophageal surgery in a district general hospital?. A review of 200 consecutive cases. Ann Royal Coll Surg Engl. 2001;83:167-171.
28. Wouters MW, Wijnhoven BP, Karim-Kos HE, et al. High-volume versus lowvolume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol. 2008;15:80-87.
29. Rouvelas I, Lindblad M, Zeng W, et al. Impact of hospital volume on longtermsurvival after esophageal cancer surgery. Arch Surg. 2007;142:113-117; discussion 118.
30. Matthews HR, Powell DJ, McConkey CC. Effect of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg. 1986;73:621-623.
31. Gillison EW, Powell J, McConkey CC, et al. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg. 2002;89:344-348.
32. van Lanschot JJ, Hulscher JB, Buskens CJ, et al. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001;91:1574-1578.
33. Al-Sarira AA, David G, Willmott S, et al. Oesophagectomy practice and outcomes in England. Br J Surg. 2007;94:585-591.
34. Metzger R, Bollschweiler E, Vallbohmer D, et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality?. Dis Esophagus. 2004;17:310-314.
35. Collard JM, Otte JB, ReynaertMS, et al. Extensive lymph node clearance for cancer of the esophagus or cardia: merits and limits in reference to 5-year absolute survival. Hepatogastroenterology. 1995;42:619-627.
36. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg. 2001;234:581-587.
37. Johansson J, DeMeester TR, Hagen JA, et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg. 2004;139:627-633.
38. Herrera LJ. Extent of lymphadenectomy in esophageal cancer: how many lymph nodes is enough?. Ann Surg Oncol. 2010;17:676-678.
39. Badruddoja M. Results of esophagectomy in high-and low-volume centers. Arch Surg. 2007;142:1112-1113.
40. van Sandick JW, van Lanschot JJB, ten Kate FJW, et al. Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg. 2002;194:28-36.
41. Lerut T, Nafteux P, Moons J, et al. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. Eur J Surg Oncol. 2005;31:587-594.
42. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-226.
43. Solomon N, Zhuge Y, Cheung M, et al. The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol. 2010;17:791-803.
44. Chen YJ, Schultheiss TE, Wong JYC, et al. Impact of the Number of Resected and Involved Lymph Nodes on Esophageal Cancer Survival. J Surg Oncol. 2009;100:127-132.
45. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384-1394.
46. Yekebas EF, Schurr PG, Kaifi JT, et al. Effectiveness of radical en-blocesophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodalmicrometastases. J SurgOncol. 2006;93:541-549.
47. Kang CH, Kim YT, Jeon SH, et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007;31:154-159.
48. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality-of-life, and prognosis after extended radical lymphadenectomy for esophageal cancer -comparison of 3-field lymphadenectomy with 2-field lymphadenectomy. Ann Surg. 1995;222:654-662.
49. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-556.
50. Takeuchi H, Saikawa Y, Oyama T, et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2009;34:277-284.
51. Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42-50.
52. OrringerMB. Transhiatal esophagectomywithout thoracotomy for carcinoma of the thoracic esophagus. Ann Surg. 1984;200:282-288.
53. Orringer MB, Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg. 1978;76:643-654.
54. Yakoub D, Athanasiou T, Tekkis P, et al. Laparoscopic assisted distal gastrectomy for early gastric cancer: is it an alternative to the open approach?. Surg Oncol. 2009;18:322-333.
55. Martin RCG, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg. 2002;235:803-812.
56. Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004;91:943-947.
57. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381-390.
58. Ellis FH, Jr. , Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113:836-848.
59. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392-403.
60. SteupWH, De Leyn P, Deneffe G, et al. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85-95.
61. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg. 2002;194:285-297.
62. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
63. Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170-1176; discussion 1170-1176.
64. Visbal AL, Allen MS, Miller DL, et al. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg. 2001;71:1803-1808.
65. Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338-344.
66. Law S, Wong KH, Kwok KF, et al. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791-800.
67. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979-1984.
68. Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg. 2003;75:217-222.
69. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727-1733.
70. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastrooesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003;327:1192-1197.
71. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-1900.
72. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 0. 2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook. org. , 2008.
73. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ. 2003;327:557-560.
74. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
75. Areja D, Subhan A, Mirza MR, et al. Transhiatal versus Ivor-Lewis procedure for the treatment of Carcinoma esophagus. Pak J Surg. 2006;22:126-129.
76. Berdejo L. Transhiatal versus transthoracic esophagectomy for clinical stage I esophageal carcinoma. Hepatogastroenterology. 1995;42:789-791.
77. Bolton JS, Ochsner JL, Abdoh AA. Surgical management of esophageal cancer. A decade of change. Ann Surg. 1994;219:475-480.
78. Bonavina L. Early oesophageal cancer: results of a European multicentre survey. Group Europeen pour l'Etude des Maladies de l'Oesophage. Br J Surg. 1995;82:98-101.
79. Bousamra M, 2nd, Haasler GB, Parviz M. A decade of experience with transthoracic and transhiatal esophagectomy. Am J Surg. 2002;183:162-167.
80. Boyle MJ, Franceschi D, Livingstone AS. Transhiatal versus transthoracic esophagectomy: complication and survival rates. Am Surg. 1999;65:1137-1141; discussion 1141-1142.
81. Braghetto I, Csendes A, Cardemil G, et al. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc. 2006;20:1681-1686.
82. Caracci B, Garvin P, Kaminski DL. Surgical therapy of advanced esophageal cancer. A critical appraisal. Am J Surg. 1983;146:704-707.
83. Cariati A, Casano A, Campagna A, et al. Prognostic factors influencing morbidity and mortality in esophageal carcinoma. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:201-204.
84. Chan WH, Wong WK, Chan HS, et al. Results of surgical resection of oesophageal carcinoma in Singapore. Ann AcadMed Singapore. 2000;29:57-61.
85. Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008;85:424-429.
86. Chou SH, Kao EL, Chuang HY, et al. Transthoracic or transhiatal resection for middle-and lower-third esophageal carcinoma?. Kaohsiung J Med Sci. 2005;21:9-14.
87. Chou SH, Chuang HY, Huang MF, et al. A prospective comparison of transthoracic and transhiatal resection for esophageal carcinoma in Asians. Hepatogastroenterology. 2009;56:707-710.
88. Chu KM, Law SY, Fok M, et al. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997;174:320-324.
89. Fok M, Siu KF, Wong J. A comparison of transhiatal and transthoracic resection for carcinoma of the thoracic esophagus. Am J Surg. 1989;158:414-419.
90. Gluch L, Smith RC, Bambach CP, et al. Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg. 1999;23:271-276.
91. Gockel I, Heckhoff S, Messow CM, et al. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis?. World J Surg Oncol. 2005;3:40.
92. Goldfaden D, Orringer MB, Appelman HD, et al. Adenocarcinoma of the distal esophagus and gastric cardia. Comparison of results of transhiatal esophagectomy and thoracoabdominal esophagogastrectomy. J Thorac Cardiovasc Surg. 1986;91:242-247.
93. Goldminc M, Maddern G, Le Prise E, et al. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg. 1993;80:367-370.
94. Graham AJ, Finley RJ, Clifton JC, et al. Surgical management of adenocarcinoma of the cardia. Am J Surg. 1998;175:418-421.
95. Gupta NM. Transhiatal versus transthoracic esophagectomy for distal esophageal cancer. Asian Cardiovasc Thorac Ann. 2000;8:347-352.
96. Hankins JR, Attar S, Coughlin TR, Jr. , et al. Carcinoma of the esophagus: a comparison of the results of transhiatal versus transthoracic resection. Ann Thorac Surg. 1989;47:700-705.
97. Homesh NA, Alsabahi AA, Al-AgmarMH, et al. Transhiatal versus transthoracic resection for oesophageal carcinoma in Yemen. Singapore Med J. 2006;47:54-59.
98. Horstmann O, Verreet PR, Becker H, et al. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg. 1995;161:557-567.
99. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1001.
100. Ikeguchi M, Maeta M, Kaibara N. Limited operation for patients with T1 esophageal cancer. Langenbecks Arch Surg. 2000;385:454-458.
101. Jacobi CA, Zieren HU, Muller JM, et al. Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg. 1997;11:32-37.
102. Jauch KW, Bacha EA, Denecke H, et al. Esophageal carcinoma: prognostic features and comparison between blunt transhiatal dissection and transthoracic resection. Eur J Surg Oncol. 1992;18:553-562.
103. Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2006;32:749-755.
104. Kudo T, Siewert JR, Bartels H. Postoperative care and management following three kinds of operation for esophageal cancer. Jpn J Surg. 1990;20:645-649.
105. Makela J, Laitinen S, Kairaluoma MI. A comparison of transthoracic and transhiatal resection for thoracic oesophageal cancer. Observations of 30 years. Ann Chir Gynaecol. 1991;80:340-345.
106. Marton S, Szakmany T, Papp A, et al. Does transthoracic compared to transhiatal resection alter the early postoperative course of oesophagectomy?. Dis Esophagus. 2005;18:155-159.
107. Millikan KW, Silverstein J, Hart V, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg. 1995;130:617-624.
108. Mohsen H. Esophageal carcinoma study in 83 cases. Acta Chir Hung. 1992;33:237-245.
109. Moon MR, Schulte WJ, Haasler GB, et al. Transhiatal and transthoracic esophagectomy for adenocarcinoma of the esophagus. Arch Surg. 1992;127:951-955.
110. Morgan MA, Lewis WG, Hopper AN, et al. Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus. 2007;20:225-231.
111. Muller JM, Zieren U, Wolters U, et al. Results of esophagectomy and gastric bypass for cancer of the esophagus. Hepatogastroenterology. 1989;36:522-528
112. Naunheim KS, Hanosh J, Zwischenberger J, et al. Esophagectomy in the septuagenarian. Ann Thorac Surg. 1993;56:880-884.
113. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152-161.
114. PacM, Basoglu A, Kocak H, et al. Transhiatal versus transthoracic esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg. 1993;106:205-209.
115. Pommier RF, Vetto JT, Ferris BL, et al. Relationships between operative approaches and outcomes in esophageal cancer. Am J Surg. 1998;175:422-425.
116. Putman JB, Suell DM, McMurtey MJ, et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg. 1994;57:319-325.
117. Saha AK, Sutton CD, Sue-Ling H, et al. Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma. Surg Endosc. 2009;23:119-124.
118. Sato N, Kusama A, Ohkawa A, et al. Resting energy expenditure in patients undergoing transhiatal or transthoracic oesophagectomy for carcinoma of the thoracic oesophagus. Br J Surg. 1993;80:1413-1415.
119. Shahian DM, Neptune WB, Ellis FH, Jr. , et al. Transthoracic versus extrathoracic esophagectomy: mortality, morbidity, and long-term survival. Ann Thorac Surg. 1986;41:237-246.
120. Stark SP, Romberg MS, Pierce GE, et al. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg. 1996;172:478-482.
121. Steiger Z, Wilson RF. Comparison of the results of esophagectomy with and without a thoracotomy. Surg Gynecol Obstet. 1981;153:653-656.
122. Suttie SA, Li AG, Quinn M, et al. The impact of operative approach on outcome of surgery for gastro-oesophageal tumours. World J Surg Oncol. 2007;5:95.
123. Svanes K, Stangeland L, Viste A, et al. Morbidity, ability to swallow, and survival, after oesophagectomy for cancer of the oesophagus and cardia. Eur J Surg. 1995;161:669-675.
124. Tilanus HW, Hop WC, Langenhorst BL, et al. Esophagectomy with or without thoracotomy. Is there any difference?. J Thorac Cardiovasc Surg. 1993;105:898-903.
125. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46-50.
126. Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132:1374-1381.
127. Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239-1246.
128. Bogoevski D, Onken F, KoenigA, et al. Is it time for a newTNMclassification in esophageal carcinoma?. Ann Surg. 2008;247:633-641.
129. Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine. www.cebm. net/levels-of-evidence. Accessed 31 January, 2010.
130. Casson AG, van Lanschot JJ. Improving outcomes after esophagectomy: the impact of operative volume. J Surg Oncol. 2005;92:262-266.
131. Ott K, Bader FG, Lordick F, et al. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center. Ann Surg Oncol. 2009;16:1017-1025.
132. Hasegawa S, Yoshikawa T, Cho H, et al. Is Adenocarcinoma of the Esophagogastric Junction Different between Japan and Western Countries?. The Incidence and Clinicopathological Features at a Japanese High-Volume Cancer Center. World J Surg. 2009;33:95-103.
133. Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction-influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246:1-8.
134. Pultrum BB, Honing J, Smit JK, et al. A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol. 2010;17: 812-820.
135. Zieren HU, Jacobi CA, Muller JM. Standards and perspectives of therapy of esophageal carcinoma. Medizinische Welt. 1996;47:55-61.
136. Scheepers JJG, van der Peet DL, Veenhof A, et al. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus. 2009;22: 42-48.
137. Khan OA, Fitzgerald JJ, Soomro I, et al. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Can. 2003;88:1549-1552.
138. Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg. 2007;246: 363-374.